English Summary
Anhui Huangshan Capsule Co., Ltd. is a China Little Giant company report summary for overseas readers. The company is associated with Anhui. The report is indexed under Biomedicine and medical devices. The Chinese report was published on 2026-06-13. The summary covers company profile, product direction, industry-chain role, technology, patent/R&D signals, scale indicators and policy-material checkpoints.
Report Snapshot
| Company | Anhui Huangshan Capsule Co., Ltd. |
| Region | Anhui |
| Industry | Biomedicine and medical devices |
| Published | 2026-06-13 |
| Chinese report | Open |
Company and Recognition Snapshot
Anhui Huangshan Capsule Co., Ltd. is indexed as a national-level Little Giant enterprise in Anhui. The English profile places the company under Biomedicine and medical devices and records 2020 2nd batch as the available recognition context.
| Recognition batch | 2020 2nd batch |
| Region | Anhui |
| Industry | Biomedicine and medical devices |
| Registered capital | RMB 299.10 million |
| Employee signal | 618 employees |
| Listed status | Listed |
| Patent signal | 136 patent-related records |
| R&D signal | 0.1265 |
Business and Industry-chain Position
Chinese public records indicate R&D, design and engineering activity. The recorded industry-chain position is Biomedicine and medical devices / Recorded position. This places the company in a policy-relevant segment for peer comparison by region, industry and batch.
Technology, Patent and R&D Signals
The public profile records 136 patent-related records. The R&D signal is: 0.1265. Patent and R&D information should be read with product direction, customer evidence and chain position rather than as isolated threshold items.
Policy-material Review Points
- Verify whether the company's main business, niche market and product evidence all point to Biomedicine and medical devices.
- Check that patent, R&D, employee and financial fields support the same core product direction.
- Compare the company with peers in the same province, industry and recognition batch before using the profile for supplier screening or policy research.
- Use the linked Chinese source report for original-language evidence and source links.
Original Report and Profile
For the underlying database record, open the English company profile. For full-length analysis, original-language wording and public evidence links, open the Chinese source report.